Immunohematology Market By Product And End User - Global Industry Analysis And Forecast To 2023
Published On : May 2022 Pages : 190 Category: Medical Devices Report Code : HC05803
Industry Outlook and Trend Analysis
The Immunohematology Market has encountered substantial development in the recent years and is anticipated to grow tremendously over the forecast period. The development is due to improvement of technologies for blood screening and new product launches. Clinics and diagnostic laboratories are switching their inclination to automated instrumentation and reconciliation of various functions in a solitary platform, which is increasing the growth of the market. Furthermore, rising accentuation on business expansion is likewise encountered in the industry. Mergers and acquisitions are dynamic and is a significant procedure adopted by key industry players as a development technique.
Product Outlook and Trend Analysis
Immunohematology reagents represented biggest offer in 2017. This section represented a major share of demand because of developing number of blood donation centres and expanded usage of reagents in the immunohematology tests. The automated analysers work on some particular reagents, accordingly making it a mandatory for hospitals and diagnostic laboratories. In immunohematology analysers, automated analyser is anticipated to be the more quickly developing product over the gauge time frame.
End User Outlook and Trend Analysis
Hospitals represented the biggest share of immunohematology market. It is compulsory for hospitals to check donated blood for diseases, set parameters of hematology segments, and perform pre-transfusion compatibility tests of donor and recipients.
Regional Outlook and Trend Analysis
In 2017, North America rose as one of the biggest markets. The high number of blood bank and blood bank facilities is the key purpose behind appeal of immunohematology products in this locale. Substantial partner of target maladies, for example, sickle cell diseases and cancer, is adding to the rising demand. Sickle cell ailment and cancer patients require different and repetitive blood transfusion. Europe is likewise anticipated that would be one of the key investors of the hematology market.
Competitive Insights
The major players in the market are Ortho Clinical Diagnostics, Siemens Healthineers, Abbott Laboratories, Grifols, Hologic, Beckman Coulter, Bio-Rad Laboratories, Immucor Inc and Becton Dickinson. The increasing merger and acquisition activities in the industry are boosting the development of the market. Acquisitions of smaller players to improve product sales have been a key strategy of growth adopted by many companies.
The Immunohematology Market is segmented as follows-
By Product:
- Immunohematology reagent
- Immunohematology analyser
By End User:
- Diagnostic laboratories
- Hospitals
- Blood banks
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Immunohematology Market, By Product, Estimates and Forecast, 2014-2023 ($Million)
· Immunohematology Analyzer
· Immunohematology Reagent
· Immunohematology Market, By End User, Estimates and Forecast, 2014-2023 ($Million)
· Hospitals
· Blood banks
· Diagnostics laboratories
· Immunohematology Market, By Region, Estimates and Forecast, 2014-2023 ($Million)
· North America
§ North America Immunohematology Market, By Country
o U.S. Immunohematology Market
o Canada Immunohematology Market
o Mexico Immunohematology Market
· Europe
§ Europe Immunohematology Market, By Country
o Germany Immunohematology Market
o UK Immunohematology Market
o France Immunohematology Market
o Russia Immunohematology Market
o Italy Immunohematology Market
o Rest of Europe Immunohematology Market
· Asia-Pacific
§ Asia-Pacific Immunohematology Market, By Country
o China Immunohematology Market
o Japan Immunohematology Market
o South Korea Immunohematology Market
o India Immunohematology Market
o Southeast Asia Immunohematology Market
o Rest of Asia-Pacific Immunohematology Market
· South America
§ South America Immunohematology Market
o Brazil Immunohematology Market
o Argentina Immunohematology Market
o Columbia Immunohematology Market
o South Africa Immunohematology Market
o Rest of South America Immunohematology Market
· Middle East and Africa
§ Middle East and Africa Immunohematology Market
o Saudi Arabia Immunohematology Market
o UAE Immunohematology Market
o Egypt Immunohematology Market
o Nigeria Immunohematology Market
o South Africa Immunohematology Market
o Rest of MEA Immunohematology Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Immunohematology Market, By Product
5.1. Introduction
5.2. Global Immunohematology Sales, Revenue and Market Share by Product (2017-2027)
5.2.1. Global Immunohematology Sales and Sales Share by Product (2017-2027)
5.2.2. Global Immunohematology Revenue and Revenue Share by Product (2017-2027)
5.3. Immunohematology Analyzer
5.3.1. Global Immunohematology Analyzer Sales and Growth Rate (2017-2027)
5.4. Immunohematology Reagent
5.4.1. Global Immunohematology Reagent Sales and Growth Rate (2017-2027)
6. Immunohematology Market, By End User
6.1. Introduction
6.2. Global Immunohematology Sales, Revenue and Market Share by End User (2017-2027)
6.2.1. Global Immunohematology Sales and Sales Share by End User (2017-2027)
6.2.2. Global Immunohematology Revenue and Revenue Share by End User (2017-2027)
6.3. Hospitals
6.3.1. Global Hospitals Sales and Growth Rate (2017-2027)
6.4. Blood banks
6.4.1. Global Blood banks Sales and Growth Rate (2017-2027)
6.5. Diagnostics laboratories
6.5.1. Global Diagnostics laboratories Sales and Growth Rate (2017-2027)
7. Immunohematology Market, By Region
7.1. Introduction
7.2. Global Immunohematology Sales, Revenue and Market Share by Regions
7.2.1. Global Immunohematology Sales by Regions (2017-2027)
7.2.2. Global Immunohematology Revenue by Regions (2017-2027)
7.3. North America Immunohematology by Countries
7.3.1. North America Immunohematology Sales and Growth Rate (2017-2027)
7.3.2. North America Immunohematology Revenue and Growth Rate (2017-2027)
7.3.3. North America Immunohematology Sales by Countries (2017-2027)
7.3.4. North America Immunohematology Revenue (Million USD) by Countries (2017-2027)
7.3.5. U.S.
7.3.5.1. United States Immunohematology Sales and Growth Rate (2017-2027)
7.3.5.2. United States Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.6. Canada
7.3.6.1. Canada Immunohematology Sales and Growth Rate (2017-2027)
7.3.6.2. Canada Immunohematology Sales (Millions USD) and Growth Rate (2017-2027)
7.3.7. Mexico
7.3.7.1. Mexico Immunohematology Sales and Growth Rate (2017-2027)
7.3.7.2. Mexico Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Immunohematology by Countries
7.4.1. Europe Immunohematology Sales and Growth Rate (2017-2027)
7.4.2. Europe Immunohematology Revenue and Growth Rate (2017-2027)
7.4.3. Europe Immunohematology Sales by Countries (2017-2027)
7.4.4. Europe Immunohematology Revenue (Million USD) by Countries (2017-2027)
7.4.5. Germany
7.4.5.1. Germany Immunohematology Sales and Growth Rate (2017-2027)
7.4.5.2. Germany Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. UK
7.4.6.1. UK Immunohematology Sales and Growth Rate (2017-2027)
7.4.6.2. UK Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. France
7.4.7.1. France Immunohematology Sales and Growth Rate (2017-2027)
7.4.7.2. France Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Russia
7.4.8.1. Russia Immunohematology Sales and Growth Rate (2017-2027)
7.4.8.2. Russia Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.9. Italy
7.4.9.1. Italy Immunohematology Sales and Growth Rate (2017-2027)
7.4.9.2. Italy Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.10. Rest of Europe
7.4.10.1. Rest of Europe Immunohematology Sales and Growth Rate (2017-2027)
7.4.10.2. Rest of Europe Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific
7.5.1. Asia-Pacific Immunohematology Sales and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Immunohematology Revenue and Growth Rate (2017-2027)
7.5.3. Asia-Pacific Immunohematology Sales by Countries (2017-2027)
7.5.4. Asia-Pacific Immunohematology Revenue (Million USD) by Countries (2017-2027)
7.5.5. China
7.5.5.1. China Immunohematology Sales and Growth Rate (2017-2027)
7.5.5.2. China Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. Japan
7.5.6.1. Japan Immunohematology Sales and Growth Rate (2017-2027)
7.5.6.2. Japan Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6.3.
7.5.7. Korea
7.5.7.1. Korea Immunohematology Sales and Growth Rate (2017-2027)
7.5.7.2. Korea Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. India
7.5.8.1. India Immunohematology Sales and Growth Rate (2017-2027)
7.5.8.2. India Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.9. Southeast Asia
7.5.9.1. Southeast Asia Immunohematology Sales and Growth Rate (2017-2027)
7.5.9.2. Southeast Asia Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.10. Rest of Asia-Pacific
7.5.10.1. Rest of Asia-Pacific Immunohematology Sales and Growth Rate (2017-2027)
7.5.10.2. Rest of Asia-Pacific Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America
7.6.1. South America Immunohematology Sales and Growth Rate (2017-2027)
7.6.2. South America Immunohematology Revenue and Growth Rate (2017-2027)
7.6.3. South America Immunohematology Sales by Countries (2017-2027)
7.6.4. South America Immunohematology Revenue (Million USD) by Countries (2017-2027)
7.6.5. Brazil
7.6.5.1. Brazil Immunohematology Sales and Growth Rate (2017-2027)
7.6.5.2. Brazil Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Argentina
7.6.6.1. Argentina Immunohematology Sales and Growth Rate (2017-2027)
7.6.6.2. Argentina Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.7. Columbia
7.6.7.1. Columbia Immunohematology Sales and Growth Rate (2017-2027)
7.6.7.2. Columbia Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.8. Rest of South America
7.6.8.1. Rest of South America Immunohematology Sales and Growth Rate (2017-2027)
7.6.8.2. Rest of South America Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa
7.7.1. Middle East and Africa Immunohematology Sales and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Immunohematology Revenue and Growth Rate (2017-2027)
7.7.3. Middle East and Africa Immunohematology Sales by Countries (2017-2027)
7.7.4. Middle East and Africa Immunohematology Revenue (Million USD) by Countries (2017-2027)
7.7.5. Saudi Arabia
7.7.5.1. Saudi Arabia Immunohematology Sales and Growth Rate (2017-2027)
7.7.5.2. Saudi Arabia Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. United Arab Emirates
7.7.6.1. United Arab Emirates Immunohematology Sales and Growth Rate (2017-2027)
7.7.6.2. United Arab Emirates Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. Egypt
7.7.7.1. Egypt Immunohematology Sales and Growth Rate (2017-2027)
7.7.7.2. Egypt Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Nigeria
7.7.8.1. Nigeria Immunohematology Sales and Growth Rate (2017-2027)
7.7.8.2. Nigeria Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. South Africa
7.7.9.1. South Africa Immunohematology Sales and Growth Rate (2017-2027)
7.7.9.2. South Africa Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.10. Rest of Middle East and Africa
7.7.10.1. Rest of Middle East and Africa Immunohematology Sales and Growth Rate (2017-2027)
7.7.10.2. Rest of Middle East and Africa Immunohematology Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Bio-Rad Laboratories, Inc.
8.1.1. Business Overview
8.1.2. Product Portfolio
8.1.3. Strategic Developments
8.1.4. Sales, Revenue and Market Share
8.2. Immucor
8.2.1. Business Overview
8.2.2. Product Portfolio
8.2.3. Strategic Developments
8.2.4. Sales, Revenue and Market Share
8.3. Grifols
8.3.1. Business Overview
8.3.2. Product Portfolio
8.3.3. Strategic Developments
8.3.4. Sales, Revenue and Market Share
8.4. BD (Becton Dickinson)
8.4.1. Business Overview
8.4.2. Product Portfolio
8.4.3. Strategic Developments
8.4.4. Sales, Revenue and Market Share
8.5. Hologic, Inc.
8.5.1. Business Overview
8.5.2. Product Portfolio
8.5.3. Strategic Developments
8.5.4. Sales, Revenue and Market Share
8.6. Siemens Healthcare GmbH
8.6.1. Business Overview
8.6.2. Product Portfolio
8.6.3. Strategic Developments
8.6.4. Sales, Revenue and Market Share
8.7. ThermoFisher
8.7.1. Business Overview
8.7.2. Product Portfolio
8.7.3. Strategic Developments
8.7.4. Sales, Revenue and Market Share
8.8. Abbott
8.8.1. Business Overview
8.8.2. Product Portfolio
8.8.3. Strategic Developments
8.8.4. Sales, Revenue and Market Share
8.9. Beckman Coulter, Inc.
8.9.1. Business Overview
8.9.2. Product Portfolio
8.9.3. Strategic Developments
8.9.4. Sales, Revenue and Market Share
8.10. Roche Diagnostics Corporation
8.10.1. Business Overview
8.10.2. Product Portfolio
8.10.3. Strategic Developments
8.10.4. Sales, Revenue and Market Share
9. Global Immunohematology Market Competition, by Manufacturer
9.1. Global Immunohematology Sales and Market Share by Manufacturer (2017-2017)
9.2. Global Immunohematology Revenue and Market Share by Manufacturer (2017-2017)
9.3. Global Immunohematology Price by Manufacturer (2017-2017)
9.4. Top 5 Immunohematology Manufacturer Market Share
9.5. Market Competition Trend
10. Immunohematology Market Forecast (2027-2023)
10.1. Global Immunohematology Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
10.2. Immunohematology Market Forecast by Regions (2027-2023)
10.2.1. North America Immunohematology Market Forecast (2027-2023)
10.2.1.1. United States Immunohematology Market Forecast (2027-2023)
10.2.1.2. Canada Immunohematology Market Forecast (2027-2023)
10.2.1.3. Mexico Immunohematology Market Forecast (2027-2023)
10.2.2. Europe Immunohematology Market Forecast (2027-2023)
10.2.2.1. Germany Immunohematology Market Forecast (2027-2023)
10.2.2.2. United Kingdom Immunohematology Market Forecast (2027-2023)
10.2.2.3. France Immunohematology Market Forecast (2027-2023)
10.2.2.4. Russia Immunohematology Market Forecast (2027-2023)
10.2.2.5. Italy Immunohematology Market Forecast (2027-2023)
10.2.2.6. Rest of the Europe Immunohematology Market Forecast (2027-2023)
10.2.3. Asia-Pacific Immunohematology Market Forecast (2027-2023)
10.2.3.1. China Immunohematology Market Forecast (2027-2023)
10.2.3.2. Japan Immunohematology Market Forecast (2027-2023)
10.2.3.3. Korea Immunohematology Market Forecast (2027-2023)
10.2.3.4. India Immunohematology Market Forecast (2027-2023)
10.2.3.5. Southeast Asia Immunohematology Market Forecast (2027-2023)
10.2.3.6. Rest of Asia-Pacific Immunohematology Market Forecast (2027-2023)
10.2.4. South America Immunohematology Market Forecast (2027-2023)
10.2.4.1. Brazil Immunohematology Market Forecast (2027-2023)
10.2.4.2. Argentina Immunohematology Market Forecast (2027-2023)
10.2.4.3. Columbia Immunohematology Market Forecast (2027-2023)
10.2.4.4. Rest of South America Immunohematology Market Forecast (2027-2023)
10.2.5. Middle East and Africa Immunohematology Market Forecast (2027-2023)
10.2.5.1. Saudi Arabia Immunohematology Market Forecast (2027-2023)
10.2.5.2. UAE Immunohematology Market Forecast (2027-2023)
10.2.5.3. Egypt Immunohematology Market Forecast (2027-2023)
10.2.5.4. Nigeria Immunohematology Market Forecast (2027-2023)
10.2.5.5. South Africa Immunohematology Market Forecast (2027-2023)
10.2.5.6. Rest of MEA Immunohematology Market Forecast (2027-2023)
10.3. Immunohematology Market Forecast by Product (2027-2023)
10.3.1. Global Immunohematology Sales Forecast by Product (2027-2023)
10.3.2. Global Immunohematology Sales Market Share Forecast by Product (2027-2023)
10.4. Immunohematology Market Forecast by End User (2027-2023)
10.4.1. Global Immunohematology Sales Forecast by End User (2027-2023)
10.4.2. Global Immunohematology Sales Market Share Forecast by End User (2027-2023)
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Immunohematology Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|